198 related articles for article (PubMed ID: 26656689)
21. Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor.
Perera KD; Rathnayake AD; Liu H; Pedersen NC; Groutas WC; Chang KO; Kim Y
Vet Microbiol; 2019 Oct; 237():108398. PubMed ID: 31585653
[TBL] [Abstract][Full Text] [Related]
22. Structural Basis for the Inhibition of Coronaviral Main Proteases by a Benzothiazole-Based Inhibitor.
Hu X; Lin C; Xu Q; Zhou X; Zeng P; McCormick PJ; Jiang H; Li J; Zhang J
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146880
[TBL] [Abstract][Full Text] [Related]
23. Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis.
Sharun K; Tiwari R; Dhama K
Ann Med Surg (Lond); 2021 Jan; 61():122-125. PubMed ID: 33456770
[TBL] [Abstract][Full Text] [Related]
24. Feline infectious peritonitis: still an enigma?
Kipar A; Meli ML
Vet Pathol; 2014 Mar; 51(2):505-26. PubMed ID: 24569616
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II.
Takano T; Nakano K; Doki T; Hohdatsu T
Arch Virol; 2015 May; 160(5):1163-70. PubMed ID: 25701212
[TBL] [Abstract][Full Text] [Related]
26. Protease inhibitors broadly effective against feline, ferret and mink coronaviruses.
Perera KD; Galasiti Kankanamalage AC; Rathnayake AD; Honeyfield A; Groutas W; Chang KO; Kim Y
Antiviral Res; 2018 Dec; 160():79-86. PubMed ID: 30342822
[TBL] [Abstract][Full Text] [Related]
27. Phylogenetic analysis of feline infectious peritonitis virus, feline enteric coronavirus, and severe acute respiratory syndrome coronavirus 2 of cats in Surabaya, Indonesia.
Aksono EB; Iradatya KR; Sucipto TH; Fajar NS; Yuniarti WM
Vet World; 2023 Jan; 16(1):76-81. PubMed ID: 36855370
[TBL] [Abstract][Full Text] [Related]
28. Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats.
Izes AM; Yu J; Norris JM; Govendir M
Vet Q; 2020 Dec; 40(1):322-330. PubMed ID: 33138721
[TBL] [Abstract][Full Text] [Related]
29. Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease.
Paasche A; Zipper A; Schäfer S; Ziebuhr J; Schirmeister T; Engels B
Biochemistry; 2014 Sep; 53(37):5930-46. PubMed ID: 25196915
[TBL] [Abstract][Full Text] [Related]
30. Design of wide-spectrum inhibitors targeting coronavirus main proteases.
Yang H; Xie W; Xue X; Yang K; Ma J; Liang W; Zhao Q; Zhou Z; Pei D; Ziebuhr J; Hilgenfeld R; Yuen KY; Wong L; Gao G; Chen S; Chen Z; Ma D; Bartlam M; Rao Z
PLoS Biol; 2005 Oct; 3(10):e324. PubMed ID: 16128623
[TBL] [Abstract][Full Text] [Related]
31. ERDRP-0519 inhibits feline coronavirus in vitro.
Camero M; Lanave G; Catella C; Lucente MS; Sposato A; Mari V; Tempesta M; Martella V; Buonavoglia A
BMC Vet Res; 2022 Jan; 18(1):55. PubMed ID: 35078478
[TBL] [Abstract][Full Text] [Related]
32. Feline Infectious Peritonitis Virus Nsp5 Inhibits Type I Interferon Production by Cleaving NEMO at Multiple Sites.
Chen S; Tian J; Li Z; Kang H; Zhang J; Huang J; Yin H; Hu X; Qu L
Viruses; 2019 Dec; 12(1):. PubMed ID: 31905881
[TBL] [Abstract][Full Text] [Related]
33. Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein.
Rottier PJ; Nakamura K; Schellen P; Volders H; Haijema BJ
J Virol; 2005 Nov; 79(22):14122-30. PubMed ID: 16254347
[TBL] [Abstract][Full Text] [Related]
34. Screening and identification of T helper 1 and linear immunodominant antibody-binding epitopes in spike 1 domain and membrane protein of feline infectious peritonitis virus.
Takano T; Morioka H; Gomi K; Tomizawa K; Doki T; Hohdatsu T
Vaccine; 2014 Apr; 32(16):1834-40. PubMed ID: 24530149
[TBL] [Abstract][Full Text] [Related]
35. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.
Takano T; Satoh K; Doki T; Tanabe T; Hohdatsu T
Viruses; 2020 May; 12(5):. PubMed ID: 32456286
[TBL] [Abstract][Full Text] [Related]
36. Virucidal and antiviral effects of Thymus vulgaris essential oil on feline coronavirus.
Catella C; Camero M; Lucente MS; Fracchiolla G; Sblano S; Tempesta M; Martella V; Buonavoglia C; Lanave G
Res Vet Sci; 2021 Jul; 137():44-47. PubMed ID: 33932822
[TBL] [Abstract][Full Text] [Related]
37. Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus.
Zhou M; Han Y; Li M; Ye G; Peng G
Virol Sin; 2021 Dec; 36(6):1421-1430. PubMed ID: 34228261
[TBL] [Abstract][Full Text] [Related]
38. First study on
Triratapiban C; Lueangaramkul V; Phecharat N; Pantanam A; Lekcharoensuk P; Theerawatanasirikul S
Vet World; 2023 Mar; 16(3):618-630. PubMed ID: 37041840
[TBL] [Abstract][Full Text] [Related]
39. Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M
Sacco MD; Ma C; Lagarias P; Gao A; Townsend JA; Meng X; Dube P; Zhang X; Hu Y; Kitamura N; Hurst B; Tarbet B; Marty MT; Kolocouris A; Xiang Y; Chen Y; Wang J
Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33158912
[TBL] [Abstract][Full Text] [Related]
40. In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virus.
Doki T; Takahashi K; Hasegawa N; Takano T
Res Vet Sci; 2022 May; 144():27-33. PubMed ID: 35033848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
